Evidence map›Paper›PMID 34659436›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

Based on UPLC-Q-TOF-MS/MS, Systematic Network Pharmacology, and Molecular Docking to Explore the Potential Mechanism of Fructus Aurantii for Major Depression Disorder.

Yating Xie, Ying Liu, Peng Zheng, Tao Zhang, Xianwen Ye, Minmin Liu, Min Huang, Quan Wan, Jinlian Zhang

Abstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yating XieSchool of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330004, China.ORCID https://orcid.org/0000-0002-5998-410X
Ying LiuSchool of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330004, China.ORCID https://orcid.org/0000-0001-9147-5383
Peng ZhengSchool of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330004, China.ORCID https://orcid.org/0000-0003-4521-3651
Tao ZhangSchool of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330004, China.ORCID https://orcid.org/0000-0001-5329-8494
Xianwen YeSchool of Chinese Material Medica, Beijing University of Chinese Medicine, Beijing 100102, China.ORCID https://orcid.org/0000-0003-0622-6951
Minmin LiuSchool of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330004, China.ORCID https://orcid.org/0000-0002-2318-8726
Min HuangSchool of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330004, China.ORCID https://orcid.org/0000-0001-5026-2963
Quan WanSchool of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330004, China.ORCID https://orcid.org/0000-0002-2603-3092
Jinlian ZhangSchool of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330004, China.ORCID https://orcid.org/0000-0001-5327-8020

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMajor Depression Disorder (MDD) is a common mental disease that has become one of the world's major medical diseases. Currently, the Fructus Aurantii (FA) has been widely used to treat depression. However, the active substance ingredients and potential mechanisms of the shell antidepression have not yet been clarified.

methodFirst, we used ultraperformance liquid chromatography-quadrupole/time-of-flight tandem mass (UPLC-QTOF-MS/MS) technology to identify the chemical composition of the FA. Then, it is predicted for active ingredients, pharmaceutical disease target screening by DiscoveryStudio 2016 (DS), Metascape, and other databases, PPI network diagram, and FC core pathway. Finally, the system network pharmacology results are verified by molecular contact verification.

resultsForty-six compounds in FA were identified, and twelve active ingredients were determined. Various database information, PPI network analysis of 41 intersections, and 20 core targets including DRD2, MTOR, FASP3, and PIK3P1 were integrated. Finally, the MDD treatment is indicated by molecular docking, and the most relevant potential signal pathway is the PI3K-Akt signaling pathway.

Identifiers

PMID34659436
PMCPMC8519718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.